Trials / Completed
CompletedNCT06086483
Pain Management After Adductor Canal Block for Total Knee Arthroplasty
Pain Management and Functional Recovery After Adductor Canal Block Combined With iPACK Block for Total Knee Arthroplasty. A Prospective, Randomized, Double-blinded Clinical Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 361 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels.
Detailed description
The Interspace between the popliteal artery and capsule of the posterior knee, or iPACK block, together with the Adductor Canal block (ACB), has been described and shows promise in providing analgesia to the knee joint. However, the effect of these two blocks on postoperative pain levels, functional recovery, and stress response is uncertain. This study compares a preoperative iPACK and ACB block to Sham blocks before total knee arthroplasty under spinal anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine 0.2% Injectable Solution | 20 mL 0.5% ropivacaine was injected into the PENG block 20 mL 0.5% ropivacaine was injected into the Adductor Canal block |
| DRUG | 0.9%sodium chloride | 20 mL 0.9% sodium chloride was injected into the PENG block 20 mL 0.5% sodium chloride was injected into the Adductor Canal block |
Timeline
- Start date
- 2020-06-18
- Primary completion
- 2022-07-20
- Completion
- 2023-08-24
- First posted
- 2023-10-17
- Last updated
- 2023-10-17
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06086483. Inclusion in this directory is not an endorsement.